ArticleFrontiers in immunology2026

Docetaxel enhances Vβ-directed T-cell activation and antitumor immunity mediated by a bifunctional TCR agonist in breast and prostate cancer models.

Jonelle K Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.